Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04576897 · ClinicalTrials.gov registry record · NA

Velacur by Sonic Incytes for Portal Hypertension

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT04576897: Completed NA study, sponsored by Indiana University.

NCT04576897 is a NA study that has completed, run by Indiana University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04576897, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.

Primary Outcome

Comparing the performance of Velacur by Sonic Incytes to transient elastography via FibroScan® in the same patient population to determine if either test is more accurate in correlating with compensated advanced chronic liver disease (cACLD) for participants with and without esophageal varices.

Interventions

  • DIAGNOSTIC_TEST Velacur

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-02-01
Est. Completion 2022-04-19
Phase NA
Indiana University

890 total trials

What the finished NCT04576897 record still lists

NCT04576897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Velacur is the first listed.

NCT04576897 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04576897 about?

NCT04576897 is a clinical study titled "Velacur by Sonic Incytes for Portal Hypertension". This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.

What is the current status of trial NCT04576897?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2021-02-01. Estimated completion is 2022-04-19.

What interventions are being tested in trial NCT04576897?

The interventions under investigation include: Velacur (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04576897?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04576897's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04576897, the US trial registry maintained by the National Library of Medicine. NCT04576897 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.